Global Newborn Screening for SMA and SCID Supply, Demand and Key Producers, 2023-2029
The global Newborn Screening for SMA and SCID market size is expected to reach $ 276.3 million by 2029, rising at a market growth of 11.0% CAGR during the forecast period (2023-2029).
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
This report studies the global Newborn Screening for SMA and SCID demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newborn Screening for SMA and SCID, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newborn Screening for SMA and SCID that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newborn Screening for SMA and SCID total market, 2018-2029, (USD Million)
Global Newborn Screening for SMA and SCID total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Newborn Screening for SMA and SCID total market, key domestic companies and share, (USD Million)
Global Newborn Screening for SMA and SCID revenue by player and market share 2018-2023, (USD Million)
Global Newborn Screening for SMA and SCID total market by Type, CAGR, 2018-2029, (USD Million)
Global Newborn Screening for SMA and SCID total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Newborn Screening for SMA and SCID market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkinelmer, Thermo Fisher, ImmunoIVD and Labsystems Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newborn Screening for SMA and SCID market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Newborn Screening for SMA and SCID Market, By Region:
1. How big is the global Newborn Screening for SMA and SCID market?
2. What is the demand of the global Newborn Screening for SMA and SCID market?
3. What is the year over year growth of the global Newborn Screening for SMA and SCID market?
4. What is the total value of the global Newborn Screening for SMA and SCID market?
5. Who are the major players in the global Newborn Screening for SMA and SCID market?
6. What are the growth factors driving the market demand?
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
This report studies the global Newborn Screening for SMA and SCID demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newborn Screening for SMA and SCID, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newborn Screening for SMA and SCID that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newborn Screening for SMA and SCID total market, 2018-2029, (USD Million)
Global Newborn Screening for SMA and SCID total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Newborn Screening for SMA and SCID total market, key domestic companies and share, (USD Million)
Global Newborn Screening for SMA and SCID revenue by player and market share 2018-2023, (USD Million)
Global Newborn Screening for SMA and SCID total market by Type, CAGR, 2018-2029, (USD Million)
Global Newborn Screening for SMA and SCID total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Newborn Screening for SMA and SCID market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkinelmer, Thermo Fisher, ImmunoIVD and Labsystems Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newborn Screening for SMA and SCID market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Newborn Screening for SMA and SCID Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Instruments
- Kits
- Software
- SCID Screening
- SMA Screening
- Perkinelmer
- Thermo Fisher
- ImmunoIVD
- Labsystems Diagnostics
1. How big is the global Newborn Screening for SMA and SCID market?
2. What is the demand of the global Newborn Screening for SMA and SCID market?
3. What is the year over year growth of the global Newborn Screening for SMA and SCID market?
4. What is the total value of the global Newborn Screening for SMA and SCID market?
5. Who are the major players in the global Newborn Screening for SMA and SCID market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Newborn Screening for SMA and SCID Introduction
1.2 World Newborn Screening for SMA and SCID Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Newborn Screening for SMA and SCID Total Market by Region (by Headquarter Location)
1.3.1 World Newborn Screening for SMA and SCID Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.3 China Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.4 Europe Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.5 Japan Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.6 South Korea Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.7 ASEAN Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.8 India Newborn Screening for SMA and SCID Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Newborn Screening for SMA and SCID Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Newborn Screening for SMA and SCID Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.2 World Newborn Screening for SMA and SCID Consumption Value by Region
2.2.1 World Newborn Screening for SMA and SCID Consumption Value by Region (2018-2023)
2.2.2 World Newborn Screening for SMA and SCID Consumption Value Forecast by Region (2024-2029)
2.3 United States Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.4 China Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.5 Europe Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.6 Japan Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.7 South Korea Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.8 ASEAN Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.9 India Newborn Screening for SMA and SCID Consumption Value (2018-2029)
3 WORLD NEWBORN SCREENING FOR SMA AND SCID COMPANIES COMPETITIVE ANALYSIS
3.1 World Newborn Screening for SMA and SCID Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Newborn Screening for SMA and SCID Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Newborn Screening for SMA and SCID in 2022
3.2.3 Global Concentration Ratios (CR8) for Newborn Screening for SMA and SCID in 2022
3.3 Newborn Screening for SMA and SCID Company Evaluation Quadrant
3.4 Newborn Screening for SMA and SCID Market: Overall Company Footprint Analysis
3.4.1 Newborn Screening for SMA and SCID Market: Region Footprint
3.4.2 Newborn Screening for SMA and SCID Market: Company Product Type Footprint
3.4.3 Newborn Screening for SMA and SCID Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Newborn Screening for SMA and SCID Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Newborn Screening for SMA and SCID Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Newborn Screening for SMA and SCID Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Newborn Screening for SMA and SCID Consumption Value Comparison
4.2.1 United States VS China: Newborn Screening for SMA and SCID Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Newborn Screening for SMA and SCID Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Newborn Screening for SMA and SCID Companies and Market Share, 2018-2023
4.3.1 United States Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
4.4 China Based Companies Newborn Screening for SMA and SCID Revenue and Market Share, 2018-2023
4.4.1 China Based Newborn Screening for SMA and SCID Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
4.5 Rest of World Based Newborn Screening for SMA and SCID Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Newborn Screening for SMA and SCID Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits
5.2.3 Software
5.3 Market Segment by Type
5.3.1 World Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
5.3.2 World Newborn Screening for SMA and SCID Market Size by Type (2024-2029)
5.3.3 World Newborn Screening for SMA and SCID Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Newborn Screening for SMA and SCID Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 SCID Screening
6.2.2 SMA Screening
6.3 Market Segment by Application
6.3.1 World Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
6.3.2 World Newborn Screening for SMA and SCID Market Size by Application (2024-2029)
6.3.3 World Newborn Screening for SMA and SCID Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Perkinelmer
7.1.1 Perkinelmer Details
7.1.2 Perkinelmer Major Business
7.1.3 Perkinelmer Newborn Screening for SMA and SCID Product and Services
7.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Perkinelmer Recent Developments/Updates
7.1.6 Perkinelmer Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product and Services
7.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 ImmunoIVD
7.3.1 ImmunoIVD Details
7.3.2 ImmunoIVD Major Business
7.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product and Services
7.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ImmunoIVD Recent Developments/Updates
7.3.6 ImmunoIVD Competitive Strengths & Weaknesses
7.4 Labsystems Diagnostics
7.4.1 Labsystems Diagnostics Details
7.4.2 Labsystems Diagnostics Major Business
7.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Services
7.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Labsystems Diagnostics Recent Developments/Updates
7.4.6 Labsystems Diagnostics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Newborn Screening for SMA and SCID Industry Chain
8.2 Newborn Screening for SMA and SCID Upstream Analysis
8.3 Newborn Screening for SMA and SCID Midstream Analysis
8.4 Newborn Screening for SMA and SCID Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Newborn Screening for SMA and SCID Introduction
1.2 World Newborn Screening for SMA and SCID Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Newborn Screening for SMA and SCID Total Market by Region (by Headquarter Location)
1.3.1 World Newborn Screening for SMA and SCID Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.3 China Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.4 Europe Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.5 Japan Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.6 South Korea Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.7 ASEAN Newborn Screening for SMA and SCID Market Size (2018-2029)
1.3.8 India Newborn Screening for SMA and SCID Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Newborn Screening for SMA and SCID Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Newborn Screening for SMA and SCID Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.2 World Newborn Screening for SMA and SCID Consumption Value by Region
2.2.1 World Newborn Screening for SMA and SCID Consumption Value by Region (2018-2023)
2.2.2 World Newborn Screening for SMA and SCID Consumption Value Forecast by Region (2024-2029)
2.3 United States Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.4 China Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.5 Europe Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.6 Japan Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.7 South Korea Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.8 ASEAN Newborn Screening for SMA and SCID Consumption Value (2018-2029)
2.9 India Newborn Screening for SMA and SCID Consumption Value (2018-2029)
3 WORLD NEWBORN SCREENING FOR SMA AND SCID COMPANIES COMPETITIVE ANALYSIS
3.1 World Newborn Screening for SMA and SCID Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Newborn Screening for SMA and SCID Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Newborn Screening for SMA and SCID in 2022
3.2.3 Global Concentration Ratios (CR8) for Newborn Screening for SMA and SCID in 2022
3.3 Newborn Screening for SMA and SCID Company Evaluation Quadrant
3.4 Newborn Screening for SMA and SCID Market: Overall Company Footprint Analysis
3.4.1 Newborn Screening for SMA and SCID Market: Region Footprint
3.4.2 Newborn Screening for SMA and SCID Market: Company Product Type Footprint
3.4.3 Newborn Screening for SMA and SCID Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Newborn Screening for SMA and SCID Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Newborn Screening for SMA and SCID Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Newborn Screening for SMA and SCID Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Newborn Screening for SMA and SCID Consumption Value Comparison
4.2.1 United States VS China: Newborn Screening for SMA and SCID Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Newborn Screening for SMA and SCID Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Newborn Screening for SMA and SCID Companies and Market Share, 2018-2023
4.3.1 United States Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
4.4 China Based Companies Newborn Screening for SMA and SCID Revenue and Market Share, 2018-2023
4.4.1 China Based Newborn Screening for SMA and SCID Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
4.5 Rest of World Based Newborn Screening for SMA and SCID Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Newborn Screening for SMA and SCID Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits
5.2.3 Software
5.3 Market Segment by Type
5.3.1 World Newborn Screening for SMA and SCID Market Size by Type (2018-2023)
5.3.2 World Newborn Screening for SMA and SCID Market Size by Type (2024-2029)
5.3.3 World Newborn Screening for SMA and SCID Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Newborn Screening for SMA and SCID Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 SCID Screening
6.2.2 SMA Screening
6.3 Market Segment by Application
6.3.1 World Newborn Screening for SMA and SCID Market Size by Application (2018-2023)
6.3.2 World Newborn Screening for SMA and SCID Market Size by Application (2024-2029)
6.3.3 World Newborn Screening for SMA and SCID Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Perkinelmer
7.1.1 Perkinelmer Details
7.1.2 Perkinelmer Major Business
7.1.3 Perkinelmer Newborn Screening for SMA and SCID Product and Services
7.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Perkinelmer Recent Developments/Updates
7.1.6 Perkinelmer Competitive Strengths & Weaknesses
7.2 Thermo Fisher
7.2.1 Thermo Fisher Details
7.2.2 Thermo Fisher Major Business
7.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product and Services
7.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Recent Developments/Updates
7.2.6 Thermo Fisher Competitive Strengths & Weaknesses
7.3 ImmunoIVD
7.3.1 ImmunoIVD Details
7.3.2 ImmunoIVD Major Business
7.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product and Services
7.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 ImmunoIVD Recent Developments/Updates
7.3.6 ImmunoIVD Competitive Strengths & Weaknesses
7.4 Labsystems Diagnostics
7.4.1 Labsystems Diagnostics Details
7.4.2 Labsystems Diagnostics Major Business
7.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Services
7.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Labsystems Diagnostics Recent Developments/Updates
7.4.6 Labsystems Diagnostics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Newborn Screening for SMA and SCID Industry Chain
8.2 Newborn Screening for SMA and SCID Upstream Analysis
8.3 Newborn Screening for SMA and SCID Midstream Analysis
8.4 Newborn Screening for SMA and SCID Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Newborn Screening for SMA and SCID Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Newborn Screening for SMA and SCID Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Newborn Screening for SMA and SCID Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Newborn Screening for SMA and SCID Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Newborn Screening for SMA and SCID Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Newborn Screening for SMA and SCID Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Newborn Screening for SMA and SCID Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Newborn Screening for SMA and SCID Players in 2022
Table 12. World Newborn Screening for SMA and SCID Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Newborn Screening for SMA and SCID Company Evaluation Quadrant
Table 14. Head Office of Key Newborn Screening for SMA and SCID Player
Table 15. Newborn Screening for SMA and SCID Market: Company Product Type Footprint
Table 16. Newborn Screening for SMA and SCID Market: Company Product Application Footprint
Table 17. Newborn Screening for SMA and SCID Mergers & Acquisitions Activity
Table 18. United States VS China Newborn Screening for SMA and SCID Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Newborn Screening for SMA and SCID Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
Table 21. United States Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 23. China Based Newborn Screening for SMA and SCID Companies, Headquarters (Province, Country)
Table 24. China Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 26. Rest of World Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 29. World Newborn Screening for SMA and SCID Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (USD Million)
Table 31. World Newborn Screening for SMA and SCID Market Size by Type (2024-2029) & (USD Million)
Table 32. World Newborn Screening for SMA and SCID Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (USD Million)
Table 34. World Newborn Screening for SMA and SCID Market Size by Application (2024-2029) & (USD Million)
Table 35. Perkinelmer Basic Information, Area Served and Competitors
Table 36. Perkinelmer Major Business
Table 37. Perkinelmer Newborn Screening for SMA and SCID Product and Services
Table 38. Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Perkinelmer Recent Developments/Updates
Table 40. Perkinelmer Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Newborn Screening for SMA and SCID Product and Services
Table 44. Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. ImmunoIVD Basic Information, Area Served and Competitors
Table 48. ImmunoIVD Major Business
Table 49. ImmunoIVD Newborn Screening for SMA and SCID Product and Services
Table 50. ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ImmunoIVD Recent Developments/Updates
Table 52. Labsystems Diagnostics Basic Information, Area Served and Competitors
Table 53. Labsystems Diagnostics Major Business
Table 54. Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Services
Table 55. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 56. Global Key Players of Newborn Screening for SMA and SCID Upstream (Raw Materials)
Table 57. Newborn Screening for SMA and SCID Typical Customers
Table 1. World Newborn Screening for SMA and SCID Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Newborn Screening for SMA and SCID Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Newborn Screening for SMA and SCID Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Newborn Screening for SMA and SCID Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Newborn Screening for SMA and SCID Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Newborn Screening for SMA and SCID Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Newborn Screening for SMA and SCID Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Newborn Screening for SMA and SCID Players in 2022
Table 12. World Newborn Screening for SMA and SCID Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Newborn Screening for SMA and SCID Company Evaluation Quadrant
Table 14. Head Office of Key Newborn Screening for SMA and SCID Player
Table 15. Newborn Screening for SMA and SCID Market: Company Product Type Footprint
Table 16. Newborn Screening for SMA and SCID Market: Company Product Application Footprint
Table 17. Newborn Screening for SMA and SCID Mergers & Acquisitions Activity
Table 18. United States VS China Newborn Screening for SMA and SCID Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Newborn Screening for SMA and SCID Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
Table 21. United States Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 23. China Based Newborn Screening for SMA and SCID Companies, Headquarters (Province, Country)
Table 24. China Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 26. Rest of World Based Newborn Screening for SMA and SCID Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Newborn Screening for SMA and SCID Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Newborn Screening for SMA and SCID Revenue Market Share (2018-2023)
Table 29. World Newborn Screening for SMA and SCID Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (USD Million)
Table 31. World Newborn Screening for SMA and SCID Market Size by Type (2024-2029) & (USD Million)
Table 32. World Newborn Screening for SMA and SCID Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (USD Million)
Table 34. World Newborn Screening for SMA and SCID Market Size by Application (2024-2029) & (USD Million)
Table 35. Perkinelmer Basic Information, Area Served and Competitors
Table 36. Perkinelmer Major Business
Table 37. Perkinelmer Newborn Screening for SMA and SCID Product and Services
Table 38. Perkinelmer Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Perkinelmer Recent Developments/Updates
Table 40. Perkinelmer Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Newborn Screening for SMA and SCID Product and Services
Table 44. Thermo Fisher Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. ImmunoIVD Basic Information, Area Served and Competitors
Table 48. ImmunoIVD Major Business
Table 49. ImmunoIVD Newborn Screening for SMA and SCID Product and Services
Table 50. ImmunoIVD Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. ImmunoIVD Recent Developments/Updates
Table 52. Labsystems Diagnostics Basic Information, Area Served and Competitors
Table 53. Labsystems Diagnostics Major Business
Table 54. Labsystems Diagnostics Newborn Screening for SMA and SCID Product and Services
Table 55. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 56. Global Key Players of Newborn Screening for SMA and SCID Upstream (Raw Materials)
Table 57. Newborn Screening for SMA and SCID Typical Customers
LIST OF FIGURES
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. World Newborn Screening for SMA and SCID Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Newborn Screening for SMA and SCID Total Market Size (2018-2029) & (USD Million)
Figure 4. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 13. Newborn Screening for SMA and SCID Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 16. World Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 18. China Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 23. India Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Newborn Screening for SMA and SCID by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Newborn Screening for SMA and SCID Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Newborn Screening for SMA and SCID Markets in 2022
Figure 27. United States VS China: Newborn Screening for SMA and SCID Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Newborn Screening for SMA and SCID Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Newborn Screening for SMA and SCID Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Newborn Screening for SMA and SCID Market Size Market Share by Type in 2022
Figure 31. Instruments
Figure 32. Kits
Figure 33. Software
Figure 34. World Newborn Screening for SMA and SCID Market Size Market Share by Type (2018-2029)
Figure 35. World Newborn Screening for SMA and SCID Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Newborn Screening for SMA and SCID Market Size Market Share by Application in 2022
Figure 37. SCID Screening
Figure 38. SMA Screening
Figure 39. Newborn Screening for SMA and SCID Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. World Newborn Screening for SMA and SCID Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Newborn Screening for SMA and SCID Total Market Size (2018-2029) & (USD Million)
Figure 4. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Newborn Screening for SMA and SCID Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Newborn Screening for SMA and SCID Revenue (2018-2029) & (USD Million)
Figure 13. Newborn Screening for SMA and SCID Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 16. World Newborn Screening for SMA and SCID Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 18. China Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 23. India Newborn Screening for SMA and SCID Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Newborn Screening for SMA and SCID by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Newborn Screening for SMA and SCID Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Newborn Screening for SMA and SCID Markets in 2022
Figure 27. United States VS China: Newborn Screening for SMA and SCID Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Newborn Screening for SMA and SCID Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Newborn Screening for SMA and SCID Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Newborn Screening for SMA and SCID Market Size Market Share by Type in 2022
Figure 31. Instruments
Figure 32. Kits
Figure 33. Software
Figure 34. World Newborn Screening for SMA and SCID Market Size Market Share by Type (2018-2029)
Figure 35. World Newborn Screening for SMA and SCID Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Newborn Screening for SMA and SCID Market Size Market Share by Application in 2022
Figure 37. SCID Screening
Figure 38. SMA Screening
Figure 39. Newborn Screening for SMA and SCID Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
